Cross-species validation of human specific STR system, SureID ® 21G and SureID ® 23comp (Health Gene Technologies) in Chimpanzee (Pan Troglodytes)

The human specific commercially available STRs system are often not tested in non human primates for their cross applicability. The aim of this study is to test Cross-species validation of two commercially available human specific STR kits i.e. SureID 21G and SureID 23comp (Health Gene Technologies)...

Full description

Saved in:
Bibliographic Details
Published inBMC research notes Vol. 12; no. 1; p. 750
Main Authors Singh, Abhishek, Thakur, Mukesh, Sahajpal, Vivek, Singh, Sujeet K, Chandra, Kailash, Sharma, Arun, Devi, Nisha, Bernot, Ausma
Format Journal Article
LanguageEnglish
Published England BioMed Central 19.11.2019
BMC
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The human specific commercially available STRs system are often not tested in non human primates for their cross applicability. The aim of this study is to test Cross-species validation of two commercially available human specific STR kits i.e. SureID 21G and SureID 23comp (Health Gene Technologies) for their positive application in Chimpanzee (Pan troglodytes). In SureID 21G, 19 loci amplified and while 20 loci amplified in SureID 23comp. All the amplified loci in both STR kits were found polymorphic and the locus Amelogenin showed differential banding patterns between male and female revealing their known gender. The present study validates the applicability of these human specific STR kits in Chimpanzee that can be used in forensics analysis, paternity testing and population genetic studies.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ISSN:1756-0500
1756-0500
DOI:10.1186/s13104-019-4801-3